Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
NUS1P3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
GFPT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PRPF40A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARMC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NT5C1B-RDH14 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IPO5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PAK1IP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MEIS3P1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MRPS15 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
VCPKMT - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MRPS10 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SAE1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HIBCH - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SEH1L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NDUFS4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HSPA4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IL6ST - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LIG4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HNRNPD - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on